| Literature DB >> 24223159 |
Nurit Beyth1, Dana Kesler Shvero, Nathan Zaltsman, Yael Houri-Haddad, Itzhak Abramovitz, Michael Perez Davidi, Ervin I Weiss.
Abstract
With growing concern over bacterial resistance, the identification of new antimicrobial means is paramount. In the oral cavity microorganisms are essential to the development of periradicular diseases and are the major causative factors associated with endodontic treatment failure. As quaternary ammonium compounds have the ability to kill a wide array of bacteria through electrostatic interactions with multiple anionic targets on the bacterial surface, it is likely that they can overcome bacterial resistance. Melding these ideas, we investigated the potency of a novel endodontic sealer in limiting Enterococcus faecalis growth. We used a polyethyleneimine scaffold to synthesize nano-sized particles, optimized for incorporation into an epoxy-based endodontic sealer. The novel endodontic sealer was tested for its antimicrobial efficacy and evaluated for biocompatibility and physical eligibility. Our results show that the novel sealer foundation affixes the nanoparticles, achieving surface bactericidal properties, but at the same time impeding nanoparticle penetration into eukaryotic cells and thereby mitigating a possible toxic effect. Moreover, adequate physical properties are maintained. The nanosized quaternary amine particles interact within minutes with bacteria, triggering cell death across wide pH values. Throughout this study we demonstrate a new antibacterial perspective for endodontic sealers; a novel antibacterial, effective and safe antimicrobial means.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24223159 PMCID: PMC3819367 DOI: 10.1371/journal.pone.0078586
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Antibacterial activity of novel endodontic sealer.
Bacterial growth following direct contact with 4 weeks- aged RCS samples incorporating 0% or 1.5% (wt/wt) QPEI nanoparticles. Each point on the curve is the average absorbance (OD650nm) measured simultaneously in eight wells similarly prepared in the same microtiter plate. No bacterial growth was observed in the modified sealer. Data analysis showed total growth inhibition (6 log decrease in viable bacteria counts) in RCS samples incorporating QPEI nanoparticles (p<0.0001). RCS without nanoparticles showed <20% growth inhibition. Viable E. faecalis control count is shown as a superposed curve; right Y-axis, calculated as CFU/ml.
Figure 2SEM images of E. faecalis following contact with the novel endodontic sealer and unmodified sealer.
A) E. faecalis following 20 min direct contact with the surface of the novel endodontic sealer. Syncytium like cells and bacterial lysis can be observed. Most of the bacteria show changes in morphology with no visible signs of cell division. B) Bacteria following 20 min direct contact with a sealing material without QPEI nanoparticles, early biofilm formation with intact membrane and dividing cells can be observed. Bacteria on the surface of the novel sealer and the sealer without nanoparticles after 40 min, C and D respectively.
Antibacterial effect of eluted components on E. faecalis.
| (%) nanoparticles in RCS | 0 | 1.5 |
|
|
|
|
|
|
|
|
Inhibition halo diameter (mm) measured by two perpendicular lines.
Bacterial growth in the presence of soluble components eluted from the tested materials into the growth media expressed as percent control (control = 100%).
Figure 3Determination of the antibacterial activity of QPEI nanoparticles in suspension.
A) Viable counts of E. faecalis (CFU/ml) in DDW with QPEI nanoparticles determined in similarly prepared samples. Measurements were made at consecutive time points (0 min, 4 min, 8 min, 12 min, 30 min and 1 hr). A decrease in cell viability was recorded within 8 minutes. Scanning electron micrographs of E. faecalis. B) in DDW with QPEI nanoparticles- depicting attached nanoparticles on bacterial membranes; C) in DDW- depicting regular bacterial membranes.
Figure 4Determination of the antibacterial activity of QPEI nanoparticles at different pH values.
E. faecalis viable counts determined after 10 min incubation in DDW with and without QPEI nanoparticles at various pH values. Serial dilutions were made to determine the viable cell counts calculated as CFU/mL. The antibacterial ratio (growth inhibition) was calculated according to the equation: no. of original cells - no. of viable cells/ no. of original cells x 100. The antibacterial activity of the nanoparticles tested at different pH values showed a viable count reduction at pH values >5 and <5. At pH 5.0, the viable counts were similar to those of the control group.
Cytotoxicity of the novel endodontic sealer.
| Treatment | Well no. | Decolorization index | Cell lysis index | Cell reaction | Scale | Interpretation of cytotoxicity |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
| ||
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
| ||
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
| ||
|
|
|
|
|
|
Decolorization and Lysis Indices of L929 cell cultures treated with the negative control - high density polyethylene film; positive control – ZEDC; and the test products - RCS + 1.5% (wt/wt) QPEI nanoparticles. The median was calculated for three replicates from each test group (1 per well). The cell reaction (decolorization index/lysis index), scale and interpretation are presented for each treatment. The results show that the novel endodontic sealer is non-cytotoxic.
Physical properties of sealer incorporating QPEI nanoparticles.
| (%) nanoparticles in RCS | 0 | 1 | 1.5 | 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Solubility tests were performed in accordance with ISO 6876:2001(E) specifications for root canal sealing materials. Samples were weighed three times on an HM-200 precision scale. The mean reading was then recorded. All solubility results were in the clinically accepted range, in accordance with ISO specifications.
Thermal analysis during gradual heating (0°C – 150°C; 10°C /min) of RCS samples incorporating 0%, 1%, 1.5% or 2% QPEI nanoparticles. Analysis of all samples was performed using a differential scanning calorimeter (DSC) device. Samples were cooled to 0°C and then heated to 150°C at a heating rate of 10°C/min. Thermal transition values were calculated using STAR software. All thermal transitions were in the same clinically accepted range.
Flow tests were conducted according to ISO 6876:2001(E) specifications. Three determinations were made and the mean value was calculated to the nearest millimeter. The minimal acceptable diameter was 20 mm. The results of all the test groups were in the clinically accepted range, in accordance with ISO specifications.